Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025
Evotec SE has scheduled the announcement of its first quarter 2025 financial results for Tuesday, May 6, 2025. The company will host a conference call and webcast to discuss the quarterly performance and provide business updates.
The event details include:
- Date: Tuesday, May 6, 2025
- Time: 2:00 PM CEST (1:00 PM BST, 8:00 AM EDT)
- Format: Audio webcast with presentation slides
- Language: English
Participants can join via web or phone, with pre-registration required for dial-in access. The presentation will be available simultaneously for phone participants, and an on-demand version will be accessible through Evotec's website under Financial Publications.
Evotec SE ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per martedì 6 maggio 2025. L'azienda organizzerà una conference call e una webcast per discutere le performance trimestrali e fornire aggiornamenti aziendali.
I dettagli dell'evento sono i seguenti:
- Data: martedì 6 maggio 2025
- Orario: 14:00 CEST (13:00 BST, 8:00 EDT)
- Formato: webcast audio con slide di presentazione
- Lingua: inglese
I partecipanti potranno collegarsi via web o telefono, con preregistrazione obbligatoria per l'accesso telefonico. La presentazione sarà disponibile simultaneamente per chi partecipa telefonicamente e una versione on-demand sarà accessibile sul sito di Evotec nella sezione Pubblicazioni Finanziarie.
Evotec SE ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el martes 6 de mayo de 2025. La compañía realizará una conferencia telefónica y una webcast para analizar el desempeño trimestral y ofrecer actualizaciones comerciales.
Los detalles del evento son:
- Fecha: martes 6 de mayo de 2025
- Hora: 14:00 CEST (13:00 BST, 8:00 EDT)
- Formato: webcast de audio con diapositivas de presentación
- Idioma: inglés
Los participantes pueden unirse vía web o teléfono, siendo necesaria la preregistración para el acceso telefónico. La presentación estará disponible simultáneamente para quienes participen por teléfono y una versión bajo demanda estará accesible en el sitio web de Evotec en la sección de Publicaciones Financieras.
Evotec SE는 2025년 1분기 재무 결과 발표를 2025년 5월 6일 화요일로 예정했습니다. 회사는 분기 실적과 사업 업데이트를 논의하기 위해 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
행사 세부 사항은 다음과 같습니다:
- 일자: 2025년 5월 6일 화요일
- 시간: 오후 2시 CEST (오후 1시 BST, 오전 8시 EDT)
- 형식: 프레젠테이션 슬라이드가 포함된 오디오 웹캐스트
- 언어: 영어
참가자는 웹 또는 전화로 참여할 수 있으며, 전화 접속을 위해 사전 등록이 필요합니다. 발표는 전화 참가자에게도 동시에 제공되며, 온디맨드 버전은 Evotec 웹사이트의 금융 출판물 섹션에서 이용할 수 있습니다.
Evotec SE a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le mardi 6 mai 2025. La société organisera une conférence téléphonique et un webcast pour discuter des performances trimestrielles et fournir des mises à jour commerciales.
Les détails de l'événement sont les suivants :
- Date : mardi 6 mai 2025
- Heure : 14h00 CEST (13h00 BST, 8h00 EDT)
- Format : webcast audio avec diapositives de présentation
- Langue : anglais
Les participants peuvent se joindre via le web ou par téléphone, une préinscription étant requise pour l'accès par téléphone. La présentation sera disponible simultanément pour les participants téléphoniques, et une version à la demande sera accessible sur le site d'Evotec dans la section Publications Financières.
Evotec SE hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Dienstag, den 6. Mai 2025, geplant. Das Unternehmen wird eine Telefonkonferenz und einen Webcast veranstalten, um die Quartalsergebnisse zu besprechen und Geschäftsaktualisierungen zu geben.
Details der Veranstaltung:
- Datum: Dienstag, 6. Mai 2025
- Uhrzeit: 14:00 Uhr MESZ (13:00 Uhr BST, 8:00 Uhr EDT)
- Format: Audiowebcast mit Präsentationsfolien
- Sprache: Englisch
Teilnehmer können per Web oder Telefon teilnehmen, eine Voranmeldung ist für den Telefoneinwahlzugang erforderlich. Die Präsentation wird gleichzeitig für Telefonteilnehmer verfügbar sein, und eine On-Demand-Version wird auf der Evotec-Website unter Finanzpublikationen zugänglich sein.
- None.
- None.
HAMBURG, DE / ACCESS Newswire / April 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its interim statement for the first quarter of 2025 on Tuesday, 6 May 2025.
The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call will be held in English.
Webcast details
Date: Tuesday, 6 May 2025
Time: 2.00 pm CEST (1.00 pm BST, 8.00 am EDT)
To join the audio webcast and to access the presentation slides, please register via this link .
The on-demand version of the webcast will be available on our website: Financial Publications - Evotec.
Conference call details
To join via phone, please pre-register via this link . You will then receive a confirmation email with dedicated dial-in details such as telephone number, access code and PIN to access the call.
A simultaneous slide presentation for participants dialing in via phone is available under this link .
About Evotec SE
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company's multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec provides high value pipeline co-creating partnerships and solutions to all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 100 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 4,800 highly qualified people. The Company's sites in Europe and the USA offer highly synergistic technologies and services and operate as complementary clusters of excellence. For additional information please go to www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn .
Forward-looking statements
This announcement contains forward-looking statements concerning future events, including the proposed offering and listing of Evotec's securities. Words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "should," "target," "would" and variations of such words and similar expressions are intended to identify forward-looking statements. Such statements include comments regarding Evotec's expectations for revenues, Group EBITDA and unpartnered R&D expenses. These forward-looking statements are based on the information available to, and the expectations and assumptions deemed reasonable by Evotec at the time these statements were made. No assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of Evotec. Evotec expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Evotec's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
For further information, please contact:
Investor Relations
Volker Braun
EVP Head of Global Investor Relations & ESG
Volker.Braun@evotec.com
SOURCE: Evotec SE
View the original press release on ACCESS Newswire
FAQ
When will Evotec (EVO) release Q1 2025 earnings?
What time is Evotec's Q1 2025 earnings call?
How can investors join Evotec's Q1 2025 earnings webcast?
Will Evotec's Q1 2025 earnings call be available on-demand?
Which stock exchanges is Evotec (EVO) listed on?
